Proposed Data Collection Submitted for Public Comment and Recommendations, 34631-34633 [2020-12244]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 85, Number 109 (Friday, June 5, 2020)]
[Notices]
[Pages 34631-34633]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12244]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-20-1074; Docket No. CDC-2020-0064]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Colorectal Cancer Control Program 
(CRCCP) Monitoring Activities. CDC is requesting a revision to OMB No. 
0920-1074 to include a redesigned survey, a redesigned clinic-level 
data collection instrument, and a new quarterly awardee-level program 
update survey.

DATES: CDC must receive written comments on or before August 4, 2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0064 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.


[[Page 34632]]


    Please note:  Submit all comments through the Federal 
eRulemaking portal (regulations.gov) or by U.S. mail to the address 
listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), Federal agencies must obtain approval from the Office of 
Management and Budget (OMB) for each collection of information they 
conduct or sponsor. In addition, the PRA also requires Federal agencies 
to provide a 60-day notice in the Federal Register concerning each 
proposed collection of information, including each new proposed 
collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

Colorectal Cancer Control Program (CRCCP) Monitoring Activities (OMB 
Control No. 0920-1074, Exp. 7/31/2020)--Revision--National Center for 
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for 
Disease Control and Prevention (CDC)

Background and Brief Description

    CDC is requesting a revision to Colorectal Cancer Control Program 
(CRCCP) Monitoring Activities (OMB Control No. 0920-1074). Based on 
feedback from awardees and internal subject matter experts, CDC 
proposes use of a revised annual grantee survey instrument (renamed, 
Annual Awardee Survey), a revised clinic-level data collection 
instrument, and a new awardee-level quarterly program update. The 
number of respondents will also increase from 30 to 35 awardees. Total 
estimated annualized burden will increase. OMB approval is requested 
for three years.
    Colorectal cancer (CRC) is the second leading cause of death from 
cancer in the United States among cancers that affect both men and 
women. There is substantial evidence that CRC screening reduces the 
incidence of and death from the disease. Screening for CRC can detect 
disease early when treatment is more effective, and prevent cancer by 
finding and removing precancerous polyps. Of individuals diagnosed with 
early stage CRC, more than 90% live five or more years. Despite strong 
evidence supporting screening, only 68.8% of adults currently report 
being up-to-date with CRC screening as recommended by the U.S. 
Preventive Services Task Force, with more than 22 million age-eligible 
adults estimated to be untested. To reduce CRC morbidity, mortality, 
and associated costs, use of CRC screening tests must be increased 
among age-eligible adults with the lowest CRC screening rates.
    The purpose of the Colorectal Cancer Control Program (CRCCP) is to 
partner with health systems and their individual primary care clinics 
to implement EBIs to increase CRC screening among defined populations 
of adults ages 50-75 that have CRC screening rates lower than the 
national, regional, or local rate. The previous cooperative agreement 
supporting the CRCCP (DP15-1502) funded 30 awardees that are state 
governments or bona-fide agents, universities, and tribal 
organizations. All 30 recipients received Component 1 funding, which 
required recipients to partner with health systems and their primary 
care clinics to implement at least two of four priority evidence-based 
interventions (EBIs) described in The Guide to Community Preventive 
Services as well as other supporting strategies. In addition, six 
recipients received Component 2 funding to provide clinical screening 
and follow-up services for a limited number of individuals aged 50-64 
in the program's priority population who are asymptomatic, at average 
risk for CRC, have inadequate or no health insurance for CRC screening, 
and are low income.
    In 2020, CDC issued a new funding opportunity, Public Health and 
Health System Partnerships to Increase Colorectal Cancer Screening in 
Clinical Settings (DP20-2002), a five-year cooperative agreement to 
increase CRC screening among defined populations of adults ages 50-75 
that have CRC screening rates lower than the national, regional, or 
local rate. Similar to DP15-1502, DP20-2002 funds recipients to partner 
with health systems and their primary care clinics to implement 
multiple EBIs, partner with organizations to support implementation of 
EBIs in those clinics, and collect high-quality clinic-level data when 
a clinic is recruited to participate (baseline) and annually thereafter 
to monitor EBI implementation and assess screening rate changes. DP20-
2002 eliminates Component 2 funding to provide direct clinical service 
delivery. However, DP20-2002 requires recipients to conduct a formal 
capacity/readiness assessment of potential clinics to implement EBIs, 
use assessment findings to select appropriate EBIs for implementation, 
and provide clinics with limited financial resources to support follow-
up colonoscopies for under- and uninsured patients after an abnormal 
CRC screening test.
    CDC proposes three information collections--a revised Annual 
Awardee Survey, a revised Clinic-Level Data Collection Instrument, and 
a new awardee-level Quarterly Program Update--to reflect the strategies 
and objectives detailed in DP20-2002.
    The previous Annual Awardee Survey assessed: (1) Program 
management, (2) health information technology, (3) partnerships, (4) 
data use, (5) training and technical assistance (TA), (6) clinic 
service delivery. The revised instrument no longer includes questions 
related to clinic service delivery since these pertained solely to 
Component 2, which is no longer funded under DP20-2002. In addition, 
many program management questions were eliminated and will now be 
gathered via the Quarterly Program Update on a quarterly basis to 
better inform CDC TA. Several data use questions were eliminated as 
they did not yield meaningful data to inform

[[Page 34633]]

CDC TA during the previous funding cycle.
    The previous Clinic-level Data Collection instrument assessed: (1) 
Health system and clinic characteristics, (2) EBI and supporting 
activities implementation within clinics; (3) monitoring and quality 
improvement activities, and (4)CRC screening rates. The revised 
instrument was reorganized (e.g., sections merged, variables moved to 
new sections) for increased efficiency and to improve overall data 
quality. In addition, wording and responses for many variables and 
their response options have undergone minor revisions to better capture 
awardees' partnerships with both health systems and clinics, and 
appropriate capture of baseline and annual variables. The revised 
instrument gathers information to assess health system and clinic 
characteristics; program reach; CRC screening practices and outcomes; 
clinics' quality improvement and monitoring activities; EBI 
implementation, and additional factors that affect EBI implementation 
over time.
    The new Quarterly Program Update will collect standardized awardee-
level information on aspects of program management, including (1) 
quarterly program expenditures, (2) current staff vacancies, (3) 
program successes and challenges, and (4) current TA needs. This 
information collection will provide CDC staff rapid reporting of 
programmatic information to inform their efforts to provide awardees 
with tailored TA.
    Redesigned data elements will enable CDC to better gauge progress 
in meeting CRCCP program goals and monitor implementation activities, 
evaluate outcomes, and identify awardee TA needs. In addition, data 
collected will inform program improvement and help identify successful 
activities that need to be maintained, replicated, or expanded.
    OMB approval is requested for three years. The number of awardees 
will increase from 30 awardees in DP15-1502 to 35 awardees in DP20-
2002, and the number of clinic partners is expected to increase from 12 
to 24 per awardee. Therefore, the total estimated annualized burden 
hours have increased from 204 to 663 hours.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of    Average burden
               Type of respondent                               Form name                    Number of     responses per   per  response   Total burden
                                                                                            respondents     respondent        (in hr)         (in hr)
--------------------------------------------------------------------------------------------------------------------------------------------------------
CRCCP Awardees.................................  CRCCP Annual Awardee Survey............              35               1           15/60               9
                                                 CRCCP Clinic-level Information                       35              24           43/60             602
                                                  Collection Instrument.
                                                 CRCCP Quarterly Program Update.........              35               4           22/60              52
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............             663
--------------------------------------------------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2020-12244 Filed 6-4-20; 8:45 am]
 BILLING CODE 4163-18-P